NUPR1 and neoplasm: This research unveils a novel role for NUPR1 in augmenting the efficacy of ICB therapy in HCC, providing insights into the molecular mechanisms of tumor immune evasion and outlining new strategies for targeting TAMs to boost T‐cell antitumor responses.